Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Romans-Sur-Isere – page 2

19 clinical trials in Romans-Sur-Isere, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Romans-Sur-Isere at a glance
19
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

19 trials in Romans-Sur-Isere

Open in trial search

Dermatitis atopic+1

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Glucocorticoids
  • Sponsor:Eli Lilly & Co.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive

Dermatitis atopic

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Romans-Sur-Isere

What the registry says about research in the country

01 Dermatological Research

Groundbreaking studies focusing on moderate to severe plaque psoriasis, evaluating innovative therapies including ESK-001 for long-term safety and efficacy assessment.

  • Plaque Psoriasis Treatment
  • Long-term Safety Studies
  • Treatment Response Evaluation

Multiple controlled trials examining treatment durability and patient response patterns.

02 Atopic Dermatitis Studies

Comprehensive research on atopic dermatitis treatments, including investigations of amlitelimab and lebrikizumab in various age groups and dosing regimens.

  • Pediatric Treatment Options
  • Monotherapy Evaluations
  • Long-term Effectiveness

Special focus on adolescent and pediatric populations with moderate to severe conditions.

03 Specialized Dermatological Conditions

Targeted research into specific conditions including prurigo nodularis and advanced treatment protocols for skin disorders.

  • Itch Management Studies
  • Skin Lesion Treatment
  • Novel Therapeutic Approaches

Innovative treatments focusing on symptom management and quality of life improvement.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.